Killestein J , Hoogervorst EL , Reif M , Kalkers NF , Van Loenen AC , Staats PGet al.Safety, tolerability, and efficacy of orally administered cannabinoids in MS . Neurology2002; 58: 1404-1407 .
2.
Wade DT , Robson P , House H , Makela P , Aram J.A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms . Clin Rehabil2003; 17: 21-29 .
3.
Zajicek J , Fox P , Sanders H , Wright D , Vickery J , Nunn Aet al.Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial . Lancet2003; 362: 1517-1526 .
4.
Fox P , Bain PG , Glickman S , Carroll C , Zajicek J.The effect of cannabis on tremor in patients with multiple sclerosis . Neurology2004; 62: 1105-1109 .
Metz L , Page S.Oral cannabinoids for spasticity in multiple sclerosis: will attitude continue to limit use?Lancet2003; 362: 1513-1513 .
7.
Vaney C , Heinzel-Gutenbrunner M , Jobin P , Tschopp F , Gattlen B , Hagen U , Schnelle M , Reif M.Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study . Multiple Sclerosis10: 417-442 .
8.
Brady CM , DasGupta R , Dalton C , Wiseman OJ , Berkley KJ , Fowler CJ.An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis . Multiple Sclerosis10: 425-433 .
9.
Wade DT , Makela P , Robson P , House H , Bateman C.Do cannabis based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients . Multiple Sclerosis10: 434-441 .
